<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="185221">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00682695</url>
  </required_header>
  <id_info>
    <org_study_id>R01NS036695</org_study_id>
    <nct_id>NCT00682695</nct_id>
  </id_info>
  <brief_title>Genetic and Environmental Risk Factors for Hemorrhagic Stroke</brief_title>
  <acronym>GERFHS</acronym>
  <official_title>Genetic and Environmental Risk Factors for Hemorrhagic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Neurological Disorders and Stroke (NINDS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find risk factors for hemorrhagic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hemorrhagic stroke—specifically intracranial hemorrhage (ICH) and subarachnoid hemorrhage
      (SAH)—affects 50,000 to 60,000 individuals in the United States each year. The consequences
      of this type of stroke are devastating with 40 percent of cases ending in death within 30
      days. Identifying the genetic and environmental risk factors for hemorrhagic stroke is
      beneficial and may lead to better treatments and possible preventions.

      The purpose of this research study is to determine the significant environmental and genetic
      risk factors for intracerebral hemorrhage (bleeding in the brain tissue) and subarachnoid
      hemorrhage (bleeding around the brain). The researchers will look for the presence of
      several stroke-related genes and any environmental risk factors hat may contribute to stroke
      in people who have suffered a hemorrhagic stroke. Because environmental risk factors vary
      within different areas, this study will be limited to physician-reviewed cases of people who
      have had a hemorrhagic stroke and who live within a 50-mile radius of Cincinnati, Ohio.

      There are two primary hypotheses in this study:

        1. The genetic and environmental factors associated with spontaneous ICH vary with the
           location and presumed mechanisms of a rupture in the artery. To test this theory
           researchers will divide the physician-reviewed cases of ICH into groups based on the
           location of the hemorrhage in the brain and determine which risk factors are associated
           with each group.

        2. The impact of environmental and genetic risk factors for spontaneous ICH and SAH in the
           population vary by gender and race. To analyze this hypothesis the researchers will
           divide the physician-reviewed cases of SAH and ICH into groups based on gender and race
           and look to see if polymorphisms (or naturally occurring variations in DNA sequence) of
           certain stroke-related genes are associated with a certain gender or race. The healthy
           volunteers and their genetic data will play an important role in this area as the
           researchers will compare healthy participants to those with hemorrhagic stroke. The
           investigators also will look for environmental risk factors (e.g., smoking, obesity,
           diabetes, etc.) that are prevalent in the participants with hemorrhagic stroke.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 1997</start_date>
  <completion_date type="Actual">June 2007</completion_date>
  <primary_completion_date type="Actual">June 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The analysis of the presence of specific genetic markers such as APOE4, APOE2 and Alpha-1-Antitrypsin gene mutations in people with hemorrhagic stroke versus the control group.</measure>
    <time_frame>Ongoing to be completed at the end of June 2008</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of risk factors such as age, race, gender, current smoking, heavy alcohol use, use of anti-coagulants, diabetes, hemorrhagic stroke family history, hypertension, etc. in people with hemorrhagic stroke versus the control group.</measure>
    <time_frame>Ongoing to be completed at the end of June 2008</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">3187</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Healthy volunteers and people who have had a hemorrhagic stroke and live within a 50 mile radius of Cincinnati, Ohio.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood or buccal DNA
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        This study will be limited to physician-reviewed cases of people who have had a
        hemorrhagic stroke and who live within a 50-mile radius of Cincinnati, Ohio.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or older

          -  Resident (6 months or longer) within 50 miles radius of the University of Cincinnati

          -  Fulfillment of the criteria for spontaneous SAH or ICH

          -  No evidence of trauma, brain tumor/metastases or infectious processes as a cause of
             the hemorrhage

          -  Ability of the patient or legal representative to provide consent for an interview,
             blood pressure determinations and DNA sampling

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Woo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Cincinnati Academic Health Center, Department of Neurology, 260 Stetson St. Room # 2300, P.O. Box 670525</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267-0525</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002 May;33(5):1190-5.</citation>
    <PMID>11988589</PMID>
  </reference>
  <reference>
    <citation>Kissela BM, Sauerbeck L, Woo D, Khoury J, Carrozzella J, Pancioli A, Jauch E, Moomaw CJ, Shukla R, Gebel J, Fontaine R, Broderick J. Subarachnoid hemorrhage: a preventable disease with a heritable component. Stroke. 2002 May;33(5):1321-6.</citation>
    <PMID>11988610</PMID>
  </reference>
  <reference>
    <citation>Woo D, Kissela BM, Khoury JC, Sauerbeck LR, Haverbusch MA, Szaflarski JP, Gebel JM, Pancioli AM, Jauch EC, Schneider A, Kleindorfer D, Broderick JP. Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study. Stroke. 2004 Jun;35(6):1360-4. Epub 2004 Apr 15.</citation>
    <PMID>15087556</PMID>
  </reference>
  <reference>
    <citation>Woo D, Haverbusch M, Sekar P, Kissela B, Khoury J, Schneider A, Kleindorfer D, Szaflarski J, Pancioli A, Jauch E, Moomaw C, Sauerbeck L, Gebel J, Broderick J. Effect of untreated hypertension on hemorrhagic stroke. Stroke. 2004 Jul;35(7):1703-8. Epub 2004 May 20.</citation>
    <PMID>15155969</PMID>
  </reference>
  <reference>
    <citation>Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, Moomaw CJ, Schneider A, Kissela B, Kleindorfer D, Broderick JP. Racial variations in location and risk of intracerebral hemorrhage. Stroke. 2005 May;36(5):934-7. Epub 2005 Mar 24.</citation>
    <PMID>15790947</PMID>
  </reference>
  <reference>
    <citation>Sauerbeck LR, Khoury JC, Woo D, Kissela BM, Moomaw CJ, Broderick JP. Smoking cessation after stroke: education and its effect on behavior. J Neurosci Nurs. 2005 Dec;37(6):316-9, 325.</citation>
    <PMID>16396084</PMID>
  </reference>
  <reference>
    <citation>Woo D, Kaushal R, Chakraborty R, Woo J, Haverbusch M, Sekar P, Kissela B, Pancioli A, Jauch E, Kleindorfer D, Flaherty M, Schneider A, Khatri P, Sauerbeck L, Khoury J, Deka R, Broderick J. Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke. 2005 Sep;36(9):1874-9. Epub 2005 Aug 11.</citation>
    <PMID>16100021</PMID>
  </reference>
  <reference>
    <citation>Woo D, Sekar P, Chakraborty R, Haverbusch MA, Flaherty ML, Kissela BM, Kleindorfer D, Schneider A, Khoury J, Sauerbeck LR, Deka R, Broderick JP. Genetic epidemiology of intracerebral hemorrhage. J Stroke Cerebrovasc Dis. 2005 Nov-Dec;14(6):239-43.</citation>
    <PMID>16557295</PMID>
  </reference>
  <reference>
    <citation>Flaherty ML, Haverbusch M, Kissela B, Kleindorfer D, Schneider A, Sekar P, Moomaw CJ, Sauerbeck L, Broderick JP, Woo D. Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis. 2005 Nov-Dec;14(6):267-71.</citation>
    <PMID>16518463</PMID>
  </reference>
  <reference>
    <citation>Flaherty ML, Woo D, Haverbusch M, Moomaw CJ, Sekar P, Sauerbeck L, Kissela B, Kleindorfer D, Broderick JP. Potential applicability of recombinant factor VIIa for intracerebral hemorrhage. Stroke. 2005 Dec;36(12):2660-4. Epub 2005 Nov 3.</citation>
    <PMID>16269646</PMID>
  </reference>
  <reference>
    <citation>Woo D, Kaushal R, Kissela B, Sekar P, Wolujewicz M, Pal P, Alwell K, Haverbusch M, Ewing I, Miller R, Kleindorfer D, Flaherty M, Chakraborty R, Deka R, Broderick J. Association of Phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke. 2006 Feb;37(2):371-6. Epub 2005 Dec 22.</citation>
    <PMID>16373644</PMID>
  </reference>
  <reference>
    <citation>Flaherty ML, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw CJ, Sauerbeck L, Schneider A, Broderick JP, Woo D. Long-term mortality after intracerebral hemorrhage. Neurology. 2006 Apr 25;66(8):1182-6.</citation>
    <PMID>16636234</PMID>
  </reference>
  <reference>
    <citation>Flaherty ML, Haverbusch M, Sekar P, Kissela BM, Kleindorfer D, Moomaw CJ, Broderick JP, Woo D. Location and outcome of anticoagulant-associated intracerebral hemorrhage. Neurocrit Care. 2006;5(3):197-201.</citation>
    <PMID>17290088</PMID>
  </reference>
  <reference>
    <citation>Kaushal R, Pal P, Alwell K, Haverbusch M, Flaherty M, Moomaw C, Sekar P, Kissela B, Kleindorfer D, Chakraborty R, Broderick J, Deka R, Woo D. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet. 2007 Jun;121(5):601-7. Epub 2007 Mar 27.</citation>
    <PMID>17387518</PMID>
  </reference>
  <reference>
    <citation>Eden SV, Morgenstern LB, Sekar P, Moomaw CJ, Haverbusch M, Flaherty ML, Broderick JP, Woo D. The role of race in time to treatment after subarachnoid hemorrhage. Neurosurgery. 2007 May;60(5):837-43; discussion 837-43.</citation>
    <PMID>17460518</PMID>
  </reference>
  <reference>
    <citation>Kaushal R, Woo D, Pal P, Haverbusch M, Xi H, Moomaw C, Sekar P, Kissela B, Kleindorfer D, Flaherty M, Sauerbeck L, Chakraborty R, Broderick J, Deka R. Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes. BMC Med Genet. 2007 Jul 31;8:49.</citation>
    <PMID>17672902</PMID>
  </reference>
  <reference>
    <citation>Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, Moomaw CJ, Haverbusch M, Broderick JP. The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology. 2007 Jan 9;68(2):116-21.</citation>
    <PMID>17210891</PMID>
  </reference>
  <reference>
    <citation>Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B, Broderick J, Woo D. Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke. 2007 Nov;38(11):3049-51. Epub 2007 Sep 27.</citation>
    <PMID>17901378</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <lastchanged_date>January 19, 2017</lastchanged_date>
  <firstreceived_date>May 20, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cincinnati</investigator_affiliation>
    <investigator_full_name>Daniel Woo</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>brain attack</keyword>
  <keyword>hemorrhagic stroke</keyword>
  <keyword>risk factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
